A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Clinical trial NCT07065240 · RECRUITING

Trial details

NCT number: NCT07065240
Sponsor: Seaport Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)Major Depressive Disorder With Anxious Distress

Start date: 2025-06-19
Primary completion: 2027-03-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.